Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	356	344	112	71	106	197
Market Cap Growth	206.22%	206.22%	57.54%	-32.42%	-46.38%	53.54%
Enterprise Value	370	328	96	64	90	197
Last Close Price	12.76	13.32	4.38	2.82	4.29	8.13
Forward PE	33.15	57.91	79.64	-	9.98	-
PS Ratio	8.47	8.82	3.55	3.36	4.84	5047.59
PB Ratio	13.95	14.09	7.26	5.46	5.99	12.57
P/TBV Ratio	-	-	10.47	8.57	7.54	13.05
P/FCF Ratio	376.24	364.94	16.49	14.92	-	-
P/OCF Ratio	366.15	355.15	16.49	14.80	-	-
EV/Sales Ratio	9.48	8.41	3.04	3.03	4.11	5040.62
EV/FCF Ratio	392.21	348.04	14.11	13.46	-	-
Debt / Equity Ratio	1.23	1.23	0.35	0.50	0.38	0.46
Debt / FCF Ratio	31.81	31.81	0.80	1.36	-	-
Asset Turnover	0.72	0.72	1.12	0.81	0.81	0.00
Inventory Turnover	1.93	1.93	14.42	12.53	3.16	0.54
Quick Ratio	1.02	1.02	1.53	2.81	4.36	5.63
Current Ratio	2.06	2.06	1.65	3.10	5.18	6.51
Return on Equity (ROE)	-19.16%	-19.16%	-6.56%	-58.75%	-11.74%	-213.40%
Return on Assets (ROA)	-2.53%	-2.53%	-2.63%	-19.67%	-3.47%	-78.10%
Return on Capital (ROIC)	-3.62%	-3.62%	-3.68%	-23.51%	-3.96%	-89.38%
Earnings Yield	-1.08%	-1.11%	-0.83%	-12.65%	-1.85%	-14.21%
FCF Yield	0.27%	0.27%	6.06%	6.71%	-4.48%	-11.38%
Buyback Yield / Dilution	-0.97%	-0.97%	-1.99%	0.24%	-19.98%	-18.30%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q